OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study
Rie Ohyama, Shuichiro Fujinaga, Koji Sakuraya, et al.
Clinical and Experimental Nephrology (2023) Vol. 27, Iss. 10, pp. 865-872
Closed Access | Times Cited: 5
Rie Ohyama, Shuichiro Fujinaga, Koji Sakuraya, et al.
Clinical and Experimental Nephrology (2023) Vol. 27, Iss. 10, pp. 865-872
Closed Access | Times Cited: 5
Showing 5 citing articles:
Identification of Risk Factors for Relapse Following Rituximab Therapy in Children with Steroid-Sensitive Nephrotic Syndrome
Ling Chen, Zhi Chen, Yue Xi, et al.
(2025)
Closed Access
Ling Chen, Zhi Chen, Yue Xi, et al.
(2025)
Closed Access
Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome
Shuichiro Fujinaga
Pediatric Nephrology (2024) Vol. 39, Iss. 9, pp. 2821-2821
Open Access | Times Cited: 1
Shuichiro Fujinaga
Pediatric Nephrology (2024) Vol. 39, Iss. 9, pp. 2821-2821
Open Access | Times Cited: 1
Changes in adverse events after multiple rituximab courses in patients with complicated steroid-dependent nephrotic syndrome
Toshimasa Morishita, Shuichiro Fujinaga
Clinical and Experimental Nephrology (2023) Vol. 28, Iss. 3, pp. 261-262
Closed Access | Times Cited: 2
Toshimasa Morishita, Shuichiro Fujinaga
Clinical and Experimental Nephrology (2023) Vol. 28, Iss. 3, pp. 261-262
Closed Access | Times Cited: 2
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)
Kandai Nozu, Mayumi Sako, Seiji Tanaka, et al.
Clinical and Experimental Nephrology (2023) Vol. 28, Iss. 4, pp. 337-348
Open Access | Times Cited: 2
Kandai Nozu, Mayumi Sako, Seiji Tanaka, et al.
Clinical and Experimental Nephrology (2023) Vol. 28, Iss. 4, pp. 337-348
Open Access | Times Cited: 2
Optimal course of pre-emptive rituximab administration for long-term disease remission in patients with complicated steroid-dependent nephrotic syndrome requiring immunosuppressive agents after rituximab
Yusuke Gonda, Shuichiro Fujinaga
Clinical and Experimental Nephrology (2024) Vol. 28, Iss. 9, pp. 953-954
Closed Access
Yusuke Gonda, Shuichiro Fujinaga
Clinical and Experimental Nephrology (2024) Vol. 28, Iss. 9, pp. 953-954
Closed Access
Response to Fujinaga – discontinuing immunosuppression in idiopathic nephrotic syndrome
Kentaro Nishi
Pediatric Nephrology (2024) Vol. 40, Iss. 1, pp. 289-289
Open Access
Kentaro Nishi
Pediatric Nephrology (2024) Vol. 40, Iss. 1, pp. 289-289
Open Access
